Jeff Aronin has nearly 20 years of experience developing global biotech and healthcare innovation companies. His expertise in complex science, rare diseases, and drug development has made him one of the most successful and innovative leaders in the bioscience sector.
Jeff has a passion for bringing talented teams of scientists and business executives together to research drug treatments and therapies. His teams have a proven track record of bringing new medicines to market with the goal of improving the lives of often overlooked patients. Jeff and his teams have succeeded in getting 13 Novel Drug Approvals through the FDA—a success rate higher than most other peers in the U.S. healthcare sector.
In addition to putting his experience and passion to work building bioscience firms, Jeff serves as a mentor to many, sharing his expertise with budding entrepreneurs.